AHA, others urge HHS to extend Next Generation ACO Model

Apr 13, 2021 - 02:35 PM
AHA-OIG-letter

Fourteen organizations, including the AHA, yesterday urged the Department of Health and Human Services to extend the Next Generation Accountable Care Organization model through 2022, and create a permanent full-risk ACO option based on it for the future. The model currently is slated to end this year, leaving participants with the choice of moving to the Medicare Shared Savings Program ENHANCED track or out of alternative payment models. 

“While MSSP ENHANCED may be an attractive option for some, it will not meet the needs of all Next Gens,” the organizations wrote. “Specifically, Next Gen represents a more advanced, full risk (100% savings/losses) option compared to MSSP ENHANCED, which offers only 75% savings/losses. Other features of Next Gen are not available in MSSP, such as the ability to modify downstream payments, and other waiver flexibilities.” 
 

Related News Articles

Headline
Senate passes reconciliation bill with Marketplace, Medicare drug provisions
The Senate yesterday voted 51-50 to pass the Inflation Reduction Act (H.R. 5376), a roughly $700 billion social spending package that includes health care,…
Headline
Senate consideration of reconciliation bill with Marketplace, Medicare drug provisions begins Saturday
The Senate this weekend is expected to take up the Inflation Reduction Act (H.R. 5376), the latest version of the Build Back Better Act, a roughly $700 billion…
Perspective
Perspective: Rallying Support to Prevent Medicare Cuts that Threaten Access to Care
America’s hospitals and health systems — and the more than 6 million team members who go to work each day to help improve the health of their patients and…
Headline
House committee passes HHS appropriations bill for FY 2023
The House Appropriations Committee today voted 32-24 to approve legislation that would provide $242.1 billion in funding for the departments of Labor, Health…
Headline
CDC updates monkeypox guidance for clinicians
The Centers for Disease Control and Prevention yesterday updated its guidance to help clinicians evaluate and test patients with relevant history, signs and…
Headline
Senate FDA bill clears committee, would modify regulatory framework for lab developed tests  
The Senate Health, Education, Labor & Pensions Committee last night voted 13-9 to advance legislation that would reauthorize Food and Drug Administration…